ShareThis Page
Newsmaker: Dr. Jean M. Tersak |

Newsmaker: Dr. Jean M. Tersak

Adam Smeltz
| Wednesday, December 10, 2014 11:39 p.m
The California-based St. Baldrick’s Foundation awarded Dr. Jean M. Tersak a $50,000 grant to support clinical trials of pediatric cancer treatments at Children’s Hospital of Pittsburgh of UPMC.

Noteworthy: The California-based St. Baldrick’s Foundation awarded Tersak a $50,000 grant to support clinical trials of pediatric cancer treatments at Children’s Hospital of Pittsburgh of UPMC. Tersak said the money will finance improvements to make a research website at Children’s more effective and user-friendly and help to raise awareness among patients and families who want alternative or additional cancer care. Some of the money will finance a new data management program to improve clinical trials.

Age: 51

Residence: Shadyside

Occupation: Tersak is an oncologist in the pediatric hematology and oncology division at Children’s. She is principal investigator of the Children’s Oncology Group and associate director of a fellowship program at the hospital.

Education: Tersak earned a bachelor’s degree in biology in 1986, a master’s degree in physical anthropology in 1989 and a doctoral degree in medicine in 1993, all from the University of Pittsburgh.

Background: Tersak completed a fellowship at Children’s in 1999 and has worked since then at the hospital, serving as an attending physician for about 15 years. She took up pediatric cancer care with the hope of strengthening treatments and making the experience better for children, she said. She grew up in Lawrenceville.

Quote: “By improving public awareness of the trials, it makes it easier not only for families in our region but also families at greater distances to learn and be able to become part of these treatments. It’s all about curing cancer.”

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.